Marina Corrêa Freitas

Prof. Marina Corrêa Freitas

Founder & Researcher, ICBS – International Center for Biomedical & Space Sciences, Rio de Janeiro, Brazil
+3
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 January 2022 in Journal of Proteome Research
Verified
Journal Article
Closed access
TLTânia Lima
Tânia Lima
RFRita Ferreira
Rita Ferreira
Marina Corrêa FreitasMarina Corrêa Freitas
Marina Corrêa Freitas
RHRui Henrique
Rui Henrique
Rui VitorinoRui Vitorino
Rui Vitorino
Margarida FardilhaMargarida Fardilha
Margarida Fardilha

27 June 2024 in International Journal of Health Science
Verified
Journal Article
Closed access
LVLuiza Vidal
Luiza Vidal
Marina Corrêa FreitasMarina Corrêa Freitas
Marina Corrêa Freitas
RCRafael Leituga de Carvalho Cavalcante
Rafael Leituga de Carvalho Cavalcante
FCFernanda da Silveira Nunes Arcanjo Chaves
Fernanda da Silveira Nunes Arcanjo Chaves
GHGabriella Alves Villatoro El Hajj
Gabriella Alves Villatoro El Hajj
MSMyrna Maria Costa de Melo Silveira
Myrna Maria Costa de Melo Silveira
Objective: To identify and evaluate recent advances in the discovery of blood biomarkers for early diagnosis and monitoring of the progression of Alzheimer's disease, highlighting their clinical potential, sensitivity, specificity and feasibility for large-scale use. Methods: Bibliographic review carried out in the PubMed database using the search strategy: (Alzheimer's Disease) AND (Early Diagnosis) AND ((Biomarkers) OR (Blood Biomarkes)). It resulted in the selection of 19 articles from a total of 468 initially identified, based on strict inclusion and exclusion criteria Review: The potential usefulness of plasma biomarkers such as Tau protein, NFL, and beta-amyloid peptides (Aβ42 and Aβ40) is highlighted), which were shown to reflect the pathological processes of the disease and offer a less invasive diagnostic approach. Furthermore, technologies such as mass spectrometry and antibody-based assays have been identified as essential for advancing the accurate identification of these biomarkers. Final considerations: We highlight the need for more research to validate the clinical applicability of these biomarkers in different populations and stages of the disease, with the aim of integrating them effectively in the diagnosis and monitoring of Alzheimer's disease.

3 February 2025 in Revista Eletrônica Acervo Saúde
Verified
Journal Article
Open access
PDF file
LCLouissa Srama Rosner Cidral
Louissa Srama Rosner Cidral
JVJúlia Wanderley Soares de Viveiros
Júlia Wanderley Soares de Viveiros
Marina Corrêa FreitasMarina Corrêa Freitas
Marina Corrêa Freitas
GSGabriela Barbosa de Sousa
Gabriela Barbosa de Sousa
EOEduardo Lucas Orso
Eduardo Lucas Orso
MSMyrna Maria Costa de Melo Silveira
Myrna Maria Costa de Melo Silveira
Objetivo: Analisar as limitações das abordagens cirúrgicas no tratamento de astrocitomas e oligodendrogliomas, com base nos avanços na compreensão molecular desses tumores e nas inovações tecnológicas em neurocirurgia. Métodos: Foi realizada uma revisão integrativa. A busca foi feita na base PubMed Central (PMC) e após a aplicação dos critérios de inclusão e exclusão, 12 artigos foram selecionados. Resultados: Os estudos revelam que a ressecção cirúrgica é a principal abordagem terapêutica para esses tumores, embora a remoção completa seja limitada, especialmente quando localizados em áreas eloquentes do cérebro. Avanços, como a neuronavegação e o monitoramento intraoperatório, têm melhorado a precisão das ressecções, mas a recorrência tumoral, principalmente em gliomas de alto grau, continua sendo um grande desafio. O uso de terapias adjuvantes, incluindo radioterapia e quimioterapia personalizadas, mostra-se fundamental para melhorar a sobrevida dos pacientes. Considerações finais: A natureza infiltrativa dos tumores e os riscos associados às cirurgias em áreas funcionais do cérebro destacam a necessidade de equilibrar a extensão da ressecção com a preservação da funcionalidade cerebral. Novas abordagens, como a terapia térmica intersticial a laser (LITT) e o uso de tecnologias intraoperatórias avançadas, devem ser foco de futuras pesquisas.

10 March 2026 in Journal of Biomedical & Space Sciences (JBSS)
Verified
Journal Article
Open access
Marina Corrêa FreitasMarina Corrêa Freitas
Marina Corrêa Freitas
Dark energy, responsible for nearly 70% of the total energy density of the Universe, remains one of the most fundamental open problems in modern cosmology. While the ΛCDM model attributes cosmic acceleration to a cosmological constant, theoretical challenges such as the fine-tuning and coincidence problems motivate the exploration of dynamic dark energy (DDE) models. This study presents a systematic review of scalar-field dark energy models, including quintessence, k-essence, phantom, and tachyon fields, published between 2015 and 2025. Following PRISMA 2020 guidelines, literature searches were conducted in Scopus, Web of Science, and NASA ADS. From 254 identified records, 112 studies met the inclusion criteria and were analyzed. The results show that quintessence models dominate the literature and remain broadly consistent with current cosmological observations, while k-essence models provide alternative mechanisms through non-canonical kinetic terms. Phantom and tachyon models offer theoretical extensions but present stability challenges. Upcoming surveys such as Euclid, LSST, and JWST are expected to significantly improve constraints on the evolution of dark energy.

1 March 2026 in Revista Ibero-Americana de Humanidades, Ciências e Educação
Verified
Journal Article
Open access
PDF file
PBPedro Gabriel Mihomem Bueno
Pedro Gabriel Mihomem Bueno
JSJoyce Karollayne da Silva
Joyce Karollayne da Silva
Marina Corrêa FreitasMarina Corrêa Freitas
Marina Corrêa Freitas
RQRoberto Kennedy Ferreira da Silva de Queiroz
Roberto Kennedy Ferreira da Silva de Queiroz
BSBianca Carolina da Silva
Bianca Carolina da Silva
JSJoão Vitor da Silva
João Vitor da Silva
Este artigo teve como objetivo examinar, com base na literatura recente, a aplicação da polilaminina derivada da placenta na recuperação funcional após lesão medular cervical. Trata-se de uma revisão narrativa, na qual foram selecionados 11 estudos pertinentes à temática. De modo geral, os achados evidenciam que biomoléculas de origem placentária, especialmente a polilaminina, favorecem a formação de um microambiente propício à reparação neural, contribuindo para processos regenerativos no tecido medular lesionado. Nesse cenário, as investigações conduzidas no Brasil ao longo das últimas décadas têm sido determinantes para a consolidação desse biomaterial como alternativa inovadora no campo da neuroregeneração. Assim, conclui-se que sua aplicação representa uma estratégia promissora, ampliando as perspectivas terapêuticas voltadas ao tratamento da lesão medular.

27 February 2026 in Journal of Biomedical & Space Sciences (JBSS)
Verified
Journal Article
Open access
Marina Corrêa FreitasMarina Corrêa Freitas
Marina Corrêa Freitas
FVFabrício Corrêa Veloso
Fabrício Corrêa Veloso
Anxiety and depressive disorders are highly prevalent psychiatric conditions associated with significant disability worldwide. Neuroimaging has advanced understanding of their neural substrates, particularly through functional magnetic resonance imaging (fMRI) and electroencephalography (EEG). This integrative review synthesized studies published between 2013 and 2025 retrieved from PubMed, Scopus, Web of Science, and PsycINFO, including adult clinical samples diagnosed with anxiety and/or depressive disorders. Evidence consistently indicates dysregulation within fronto-limbic circuitry and large-scale brain networks, notably involving the amygdala, prefrontal cortex, anterior cingulate cortex, and default mode network. fMRI findings highlight altered functional connectivity and impaired emotional regulation, whereas EEG studies reveal abnormalities in oscillatory activity and event-related potentials linked to attentional bias and cognitive control. Although convergent neural markers emerge across modalities, methodological heterogeneity limits reproducibility and clinical application. Multimodal integration of spatial and temporal neural measures may enhance biomarker reliability and support the development of precision psychiatry approaches.